122 related articles for article (PubMed ID: 1503488)
1. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
Horiuchi M; Miyake H; Ota K
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
[TBL] [Abstract][Full Text] [Related]
2. [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
Ota K; Wakui A; Majima H; Niitani H; Inuyama Y; Ogawa M; Ariyoshi Y; Yoshida O; Taguchi T; Kimura I
Gan To Kagaku Ryoho; 1992 Jun; 19(6):855-61. PubMed ID: 1605663
[TBL] [Abstract][Full Text] [Related]
3. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
Koyama H; Ogawa M; Kuraishi Y; Tominaga K; Yoshida M; Taguchi T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1049-53. PubMed ID: 1626940
[TBL] [Abstract][Full Text] [Related]
4. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].
Furuse K; Fukuoka M; Kurita Y; Ariyoshi Y; Niitani H; Yoneda S; Fujii M; Hasegawa K; Nishiwaki Y; Tamura M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):879-84. PubMed ID: 1318698
[TBL] [Abstract][Full Text] [Related]
5. [An early phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
Gan To Kagaku Ryoho; 1992 Jun; 19(6):863-9. PubMed ID: 1605664
[TBL] [Abstract][Full Text] [Related]
6. [A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Inuyama Y; Miyake H; Horiuchi M; Hayasaki K; Komiyama S; Ota K
Gan To Kagaku Ryoho; 1992 Jun; 19(6):871-7. PubMed ID: 1605665
[TBL] [Abstract][Full Text] [Related]
7. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
Gan To Kagaku Ryoho; 1992 Apr; 19(4):483-8. PubMed ID: 1558398
[TBL] [Abstract][Full Text] [Related]
8. [Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
Kato T; Nishimura H; Yakushiji M; Noda K; Terashima Y; Takeuchi S; Takamizawa H; Suzuki M; Arai M; Ota M
Gan To Kagaku Ryoho; 1992 May; 19(5):695-701. PubMed ID: 1580643
[TBL] [Abstract][Full Text] [Related]
9. [Nedaplatin].
Ota K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):379-87. PubMed ID: 8712835
[TBL] [Abstract][Full Text] [Related]
10. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T
Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
[TBL] [Abstract][Full Text] [Related]
11. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
12. [Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer].
Xu RH; Guan ZZ; Jiang WQ; Huang H; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C; Ma ZY; Wang JH
Ai Zheng; 2002 Dec; 21(12):1354-8. PubMed ID: 12520747
[TBL] [Abstract][Full Text] [Related]
13. [Experimental evaluation of cisplatin analogous in urogenital cancer].
Machida T; Akasaka Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1386-92. PubMed ID: 2658827
[TBL] [Abstract][Full Text] [Related]
14. [Cisplatinum compounds].
Ota K
Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
[TBL] [Abstract][Full Text] [Related]
15. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
Sasaki Y; Amano T; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Kojima A; Saijo N
Cancer Res; 1991 Mar; 51(5):1472-7. PubMed ID: 1997185
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of carboplatin in non-small cell lung cancer.
Tamura T; Shinkai T; Eguchi K; Sasaki Y; Fujiwara Y; Fukuda M; Ohe Y; Nakagawa K; Minato K; Saijo N
Jpn J Clin Oncol; 1989 Mar; 19(1):51-5. PubMed ID: 2537907
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S.
Ota K; Oguma T; Shimamura K
Anticancer Res; 1994; 14(3B):1383-7. PubMed ID: 8067710
[TBL] [Abstract][Full Text] [Related]
18. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
[TBL] [Abstract][Full Text] [Related]
19. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
20. [The ototoxicity of cisplatin in the chemotherapy of tumors of the head-neck area. Our experience].
Sbalzarini G; Malusardi G; Pandolfi C; Cerri A
Minerva Med; 1990 May; 81(5):403-5. PubMed ID: 2377307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]